Direct stent implantation without predilatation through 5 French guiding catheter following transfemoral coronary angiogram: a feasibility study

Catheter Cardiovasc Interv. 2003 Nov;60(3):354-9. doi: 10.1002/ccd.10668.

Abstract

Direct stenting (DS) is accepted as reducing procedural cost and duration and 5 Fr guiding catheters as lowering peripheral vascular complications. We aimed to evaluate the feasibility and safety of both strategies. We retrospectively studied 150 consecutive patients treated with DS strategy using a 5 Fr femoral approach. A need for 6 Fr devices or balloon predilatation defined 5 Fr DS failure. Procedural success was defined as good angiographic result (residual stenosis < 30% and TIMI flow 3) without ischemic complications. A total of 161 out of 174 lesions were elected as suitable for DS. The success rate of 5 Fr DS was 87.6% (141/161 lesions). The procedural success rate was 92% (138/150 patients). The angiographic success rate was 96.3% (155/161 lesions). Other complications were six non-Q-wave MI and one repeat angioplasty for acute in-stent thrombosis. Only one major peripheral vascular complication occurred. Direct stenting through 5 Fr guiding catheters in selected lesions is safe and effective with a low incidence of peripheral arterial complications.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Angioplasty, Balloon, Coronary* / methods*
  • Biomarkers / blood
  • Blood Vessel Prosthesis Implantation / methods*
  • Cardiac Catheterization*
  • Coronary Angiography*
  • Coronary Circulation / physiology
  • Equipment Safety / instrumentation
  • Feasibility Studies
  • Female
  • Follow-Up Studies
  • Hemoglobins / metabolism
  • Humans
  • Length of Stay
  • Male
  • Middle Aged
  • Myocardial Ischemia / diagnostic imaging*
  • Myocardial Ischemia / mortality
  • Myocardial Ischemia / therapy*
  • Postoperative Complications / diagnostic imaging
  • Postoperative Complications / etiology
  • Postoperative Complications / mortality
  • Reoperation
  • Retrospective Studies
  • Stents*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Biomarkers
  • Hemoglobins